Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000150

EVP, Chief Scientific Officer sold 54 shares at $430.93 ($23,270)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-15 Sale : show line 1 in the form 10b5-1 −54 $430.93 $23,270 25,813 D
Open-market sales · 54 sh · avg $430.93 · $23,270
Loading xslF345X05/wk-form4_1715977306.xml…